Assembly Biosciences (ASMB) EBT (2010 - 2026)
Assembly Biosciences (ASMB) recorded quarterly EBT of -$9.1 million in Q1 2026, down 141.1% quarter-over-quarter from $22.1 million in Q4 2025, and down 2.96% on a YoY basis from -$9.4 million in Q1 2025.
Assembly Biosciences (ASMB) EBT (2010 - 2026) Analysis & Trends
Assembly Biosciences' EBT history runs 17 years deep, the most recent figure standing at -$9.1 million for Q1 2026.
- In Q1 2026, EBT fell 2.96% year-over-year to -$9.1 million; the TTM figure through Mar 2026 stood at -$6.4 million (up 83.88% YoY), while the FY2025 annual figure was -$6.1 million, up 84.64% from the prior year.
- EBT was -$9.1 million for Q1 2026 at Assembly Biosciences, down from $22.1 million in the prior quarter.
- In the past five years, EBT ranged from a high of $22.1 million in Q4 2025 to a low of -$24.5 million in Q2 2022.
- Historically, EBT has averaged -$12.3 million across 5 years, with a median of -$10.7 million in 2024.
- The sharpest annual moves came in 2022 and 2025: EBT fell 23.09% in 2022, then jumped 312.18% in 2025.
- A 5-year view of EBT shows it stood at -$22.4 million in 2022, then soared by 51.2% to -$10.9 million in 2023, then rose by 4.74% to -$10.4 million in 2024, then jumped by 312.18% to $22.1 million in 2025, then slumped by 141.1% to -$9.1 million in 2026.
- The last three EBT figures came in at -$9.1 million (Q1 2026), $22.1 million (Q4 2025), and -$9.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | -9.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.08 Mn |
| Dec 31, 2025 | 22.09 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Jun 30, 2025 | -10.20 Mn |
| Mar 31, 2025 | -8.82 Mn |
| Dec 31, 2024 | -10.41 Mn |
| Sep 30, 2024 | -9.61 Mn |
| Jun 30, 2024 | -10.75 Mn |
| Mar 31, 2024 | -9.08 Mn |
| Dec 31, 2023 | -10.93 Mn |
| Sep 30, 2023 | -14.42 Mn |
| Jun 30, 2023 | -16.90 Mn |
| Mar 31, 2023 | -18.95 Mn |
| Dec 31, 2022 | -22.40 Mn |
| Sep 30, 2022 | -23.15 Mn |
| Jun 30, 2022 | -24.46 Mn |
| Mar 31, 2022 | -23.09 Mn |
| Dec 31, 2021 | -62.79 Mn |
| Sep 30, 2021 | -18.80 Mn |
| Jun 30, 2021 | -23.60 Mn |